Covariation between motor signs and negative symptoms in drug-naive subjects with schizophrenia-spectrum disorders before and after antipsychotic treatment

Psychosis and Schizophrenia

Psychosis relapse during treatment with long-acting injectable antipsychotics in individuals with schizophrenia-spectrum disorders: an individual participant data meta-analysis

Lancet Psychiatry.

Rubio JM, Schoretsanitis G, John M, Tiihonen J, Taipale H, Guinart D, Malhotra AK, Correll CU, Kane JM

doi: 10.1016/S2215-0366(20)30264-9.

Psychosis and Schizophrenia

Antipsychotic drugs for the acute treatment of patients with a first episode of schizophrenia: a systematic review with pairwise and network meta-analyses

Lancet Psychiatry.

Zhu Y, Krause M, Huhn M, Rothe P, Schneider-Thoma J, Chaimani A, Li C, Davis JM, Leucht S

doi: 10.1016/S2215-

Migraine and HeadacheAnxiety and DepressionPsychosis and Schizophrenia

Cariprazine versus risperidone monotherapy for treatment of predominant negative symptoms in patients with schizophrenia: a randomised, double-blind, controlled trial

Lancet.

Németh G, Laszlovszky I, Czobor P, Szalai E, Szatmári B, Harsányi J, Barabássy Á, Debelle M, Durgam S, Bitter I, Marder S, Fleischhacker WW

doi: 10.1016/

Autism

Pre-emptive intervention versus treatment as usual for infants showing early behavioural risk signs of autism spectrum disorder: a single-blind, randomised controlled trial

Lancet Child Adolesc Health.

Whitehouse AJO, Varcin KJ, Alvares GA, Barbaro J, Bent C, Boutrus M, Chetcuti L, Cooper MN, Clark A, Davidson E, Dimov S, Dissanayake C, Doyle J, Grant M, Iacono T, Maybery M, Pillar S, Renton M, Rowbottam C, Sadka N, Segal L, Slonims V, Taylor C, Wakeling S, Wan MW, Wray J, Green J, Hudry K

doi: 10.1016/S2352-4642(19)30184-1.

Psychosis and Schizophrenia

The Latent Structure of Negative Symptoms in Schizophrenia

JAMA Psychiatry.

Strauss GP, Nuñez A, Ahmed AO, Barchard KA, Granholm E, Kirkpatrick B, Gold JM, Allen DN

doi: 10.1001/

Aging and Cognitive FunctionsPsychosis and Schizophrenia

Treatment resistant schizophrenia and neurological soft signs may converge on the same pathology: Evidence from explanatory analysis on clinical, psychopathological, and cognitive variables

Prog Neuropsychopharmacol Biol Psychiatry.

de Bartolomeis A, Prinzivalli E, Callovini G, D'Ambrosio L, Altavilla B, Avagliano C, Iasevoli F

doi: 10.1016/j.pnpbp.2017.09.002.

Anxiety and DepressionAutism

Exploring Relationships Between Negative Cognitions and Anxiety Symptoms in Youth With Autism Spectrum Disorder

Behav Ther.

Keefer A, Kreiser NL, Singh V, Blakeley-Smith A, Reaven J, Vasa RA

doi: 10.1016/j.beth.2017.12.002.

Bipolar Disorder

Long-acting injectable antipsychotics (LAIs) for maintenance treatment of bipolar and schizoaffective disorders: A systematic review

doi: 10.1016/j.euroneuro.2019.02.003.

Psychosis and Schizophrenia

Negative symptoms of schizophrenia: new developments and unanswered research questions

Lancet Psychiatry.

Galderisi S, Mucci A, Buchanan RW, Arango C

doi: 10.1016/S2215-

Related content

Psychosis relapse during treatment with long-acting injectable antipsychotics in individuals with schizophrenia-spectrum disorders: an individual participant data meta-analysis

Antipsychotic drugs for the acute treatment of patients with a first episode of schizophrenia: a systematic review with pairwise and network meta-analyses

Cariprazine versus risperidone monotherapy for treatment of predominant negative symptoms in patients with schizophrenia: a randomised, double-blind, controlled trial

Pre-emptive intervention versus treatment as usual for infants showing early behavioural risk signs of autism spectrum disorder: a single-blind, randomised controlled trial

The Latent Structure of Negative Symptoms in Schizophrenia

Treatment resistant schizophrenia and neurological soft signs may converge on the same pathology: Evidence from explanatory analysis on clinical, psychopathological, and cognitive variables

Exploring Relationships Between Negative Cognitions and Anxiety Symptoms in Youth With Autism Spectrum Disorder

Long-acting injectable antipsychotics (LAIs) for maintenance treatment of bipolar and schizoaffective disorders: A systematic review

Negative symptoms of schizophrenia: new developments and unanswered research questions